Sylvia Richard‐Bildstein

462 total citations
14 papers, 359 citations indexed

About

Sylvia Richard‐Bildstein is a scholar working on Molecular Biology, Biomedical Engineering and Organic Chemistry. According to data from OpenAlex, Sylvia Richard‐Bildstein has authored 14 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Biomedical Engineering and 4 papers in Organic Chemistry. Recurrent topics in Sylvia Richard‐Bildstein's work include Innovative Microfluidic and Catalytic Techniques Innovation (5 papers), Chemical Synthesis and Analysis (4 papers) and Computational Drug Discovery Methods (4 papers). Sylvia Richard‐Bildstein is often cited by papers focused on Innovative Microfluidic and Catalytic Techniques Innovation (5 papers), Chemical Synthesis and Analysis (4 papers) and Computational Drug Discovery Methods (4 papers). Sylvia Richard‐Bildstein collaborates with scholars based in Switzerland, Germany and China. Sylvia Richard‐Bildstein's co-authors include Christoph Boss, Christoph A. Binkert, Solange Meyer, Walter Fischli, Daniel Bur, Lars Prade, Thomas Weller, Gianvito Vilé, Andrew F. Jones and Olivier Corminboeuf and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Green Chemistry.

In The Last Decade

Sylvia Richard‐Bildstein

13 papers receiving 358 citations

Peers

Sylvia Richard‐Bildstein

PHEOH

CTM

ONCOL

Shagun Krishna India

Edwin G. Tse United Kingdom

Eleonora Gianquinto Italy

Chinedu Ogbonnia Egwu Nigeria

Erin Milner United States

Denis Platel France

Liezl Gibhard South Africa

Murray N. Robertson United Kingdom

Francis E. Agamah South Africa

Amanda Haymond United States

Shagun Krishna India

Sylvia Richard‐Bildstein

256 ×1.8

60 ×0.5

PHEOH

144 ×1.4

96 ×1.0

CTM

44 ×0.9

ONCOL

Citations per year, relative to Sylvia Richard‐Bildstein Sylvia Richard‐Bildstein (= 1×) peers Shagun Krishna

Countries citing papers authored by Sylvia Richard‐Bildstein

Since Specialization

Citations

This map shows the geographic impact of Sylvia Richard‐Bildstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia Richard‐Bildstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia Richard‐Bildstein more than expected).

Fields of papers citing papers by Sylvia Richard‐Bildstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia Richard‐Bildstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia Richard‐Bildstein. The network helps show where Sylvia Richard‐Bildstein may publish in the future.

Co-authorship network of co-authors of Sylvia Richard‐Bildstein

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvia Richard‐Bildstein. A scholar is included among the top collaborators of Sylvia Richard‐Bildstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvia Richard‐Bildstein. Sylvia Richard‐Bildstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Kimmerlin, Thierry, A. Mac Sweeney, Roland Lange, et al.. (2025). Accelerating the Hit-To-Lead Optimization of a SARS-CoV-2 Mpro Inhibitor Series by Combining High-Throughput Medicinal Chemistry and Computational Simulations. Journal of Medicinal Chemistry. 68(8). 8269–8294.

Meyer, Emmanuel A., Andrew L. Croxford, Carmela Gnerre, et al.. (2024). Discovery of the Clinical Candidate IDOR-1117-2520: A Potent and Selective Antagonist of CCR6 for Autoimmune Diseases. Journal of Medicinal Chemistry. 67(10). 8077–8098. 4 indexed citations

Tortoioli, Simone, et al.. (2020). Development of an efficient and sustainable synthesis of 2-(3-methyl-1 H -1,2,4-triazol-1-yl) acetic acid under continuous-flow conditions. Green Chemistry. 22(12). 3748–3758. 15 indexed citations

Richard‐Bildstein, Sylvia, et al.. (2020). Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239. Journal of Medicinal Chemistry. 63(24). 15864–15882. 31 indexed citations

Richard‐Bildstein, Sylvia, et al.. (2019). A Novel and Efficient Continuous-Flow Route To Prepare Trifluoromethylated N-Fused Heterocycles for Drug Discovery and Pharmaceutical Manufacturing. Industrial & Engineering Chemistry Research. 58(24). 10164–10171. 32 indexed citations

Vilé, Gianvito, G. Schmidt, Sylvia Richard‐Bildstein, & Stefan Abele. (2018). Enantiospecific cyclization of methyl N-(tert-butoxycarbonyl)-N-(3-chloropropyl)-D-alaninate to 2-methylproline derivative via ‘memory of chirality’ in flow. Journal of Flow Chemistry. 9(1). 19–25. 8 indexed citations

Vilé, Gianvito, et al.. (2018). Electrophile, Substrate Functionality, and Catalyst Effects in the Synthesis of α‐Mono and Di‐Substituted Benzylamines via Visible‐Light Photoredox Catalysis in Flow. ChemCatChem. 10(17). 3786–3794. 23 indexed citations

Corminboeuf, Olivier, Corinna Grisostomi, Sylvia Richard‐Bildstein, et al.. (2010). Design and optimization of new piperidines as renin inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(21). 6286–6290. 15 indexed citations

Corminboeuf, Olivier, Corinna Grisostomi, Sylvia Richard‐Bildstein, et al.. (2010). Piperidine-based renin inhibitors: Upper chain optimization. Bioorganic & Medicinal Chemistry Letters. 20(21). 6291–6296. 16 indexed citations

10.

Richard‐Bildstein, Sylvia, Daniel Bur, Lars Prade, et al.. (2009). New classes of potent and bioavailable human renin inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(23). 6762–6765. 15 indexed citations

11.

Bur, Daniel, Thomas Weller, Sylvia Richard‐Bildstein, et al.. (2009). Design and Preparation of Potent, Nonpeptidic, Bioavailable Renin Inhibitors. Journal of Medicinal Chemistry. 52(12). 3689–3702. 44 indexed citations

12.

Prade, Lars, Andrew F. Jones, Christoph Boss, et al.. (2005). X-ray Structure of Plasmepsin II Complexed with a Potent Achiral Inhibitor. Journal of Biological Chemistry. 280(25). 23837–23843. 75 indexed citations

13.

Boss, Christoph, Reto Brun, Walter Fischli, et al.. (2004). Inhibitors of Plasmepsin II – Potential Antimalarial Agents. CHIMIA International Journal for Chemistry. 58(9). 634–634. 5 indexed citations

14.

Boss, Christoph, Sylvia Richard‐Bildstein, Thomas Weller, et al.. (2003). Inhibitors of the Plasmodium Falciparum Parasite Aspartic Protease Plasmepsin II As Potential Antimalarial Agents. Current Medicinal Chemistry. 10(11). 883–907. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact